GB9102727D0 - Pharmaceutical agent - Google Patents

Pharmaceutical agent

Info

Publication number: GB9102727D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical agent; pharmaceutical; agent
Prior art date: 1991-02-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB919102727A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Imperial Chemical Industries Ltd

Original Assignee

Imperial Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-08

Filing date

1991-02-08

Publication date

1991-03-27

1991-02-08 Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd

1991-02-08 Priority to GB919102727A priority Critical patent/GB9102727D0/en

1991-03-27 Publication of GB9102727D0 publication Critical patent/GB9102727D0/en

1992-01-27 Priority to IE024392A priority patent/IE920243A1/en

1992-01-28 Priority to IL100793A priority patent/IL100793A0/en

1992-01-31 Priority to ZA92729A priority patent/ZA92729B/en

1992-02-03 Priority to APAP/P/1992/000355A priority patent/AP9200355A0/en

1992-02-05 Priority to HU9200354A priority patent/HUT60489A/en

1992-02-05 Priority to PCT/GB1992/000214 priority patent/WO1992013853A1/en

1992-02-05 Priority to AU11893/92A priority patent/AU1189392A/en

1992-02-05 Priority to GB9202377A priority patent/GB2252557A/en

1992-02-06 Priority to PT100097A priority patent/PT100097A/en

1992-02-07 Priority to MX9200532A priority patent/MX9200532A/en

1992-02-07 Priority to CA002060825A priority patent/CA2060825A1/en

1992-02-08 Priority to CN92101425A priority patent/CN1064809A/en

Status Pending legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

GB919102727A 1991-02-08 1991-02-08 Pharmaceutical agent Pending GB9102727D0 (en)

Priority Applications (13)

Application Number	Priority Date	Filing Date	Title
GB919102727A GB9102727D0 (en)	1991-02-08	1991-02-08	Pharmaceutical agent
IE024392A IE920243A1 (en)	1991-02-08	1992-01-27	Therapeutic agent
IL100793A IL100793A0 (en)	1991-02-08	1992-01-28	Therapeutic agents
ZA92729A ZA92729B (en)	1991-02-08	1992-01-31	Pharmaceutical agent
APAP/P/1992/000355A AP9200355A0 (en)	1991-02-08	1992-02-03	"Therapeutic agent"
GB9202377A GB2252557A (en)	1991-02-08	1992-02-05	Quinoline derivative
PCT/GB1992/000214 WO1992013853A1 (en)	1991-02-08	1992-02-05	Pharmaceutical agent
HU9200354A HUT60489A (en)	1991-02-08	1992-02-05	Process for producing 2-ethyl-4-/(2'-/1h-tetrazol-5-yl/-biphenyl-4-yl)-methoxy/-quinoline hydrochloride and pharmaceutical compositions comprising same
AU11893/92A AU1189392A (en)	1991-02-08	1992-02-05	Pharmaceutical agent
PT100097A PT100097A (en)	1991-02-08	1992-02-06	NEW THERAPEUTIC AGENTS CONSTITUTED BY QUINOLINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
MX9200532A MX9200532A (en)	1991-02-08	1992-02-07	PHARMACEUTICAL AGENT.
CA002060825A CA2060825A1 (en)	1991-02-08	1992-02-07	Therapeutic agent
CN92101425A CN1064809A (en)	1991-02-08	1992-02-08	Medicament

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB919102727A GB9102727D0 (en)	1991-02-08	1991-02-08	Pharmaceutical agent

Publications (1)

Publication Number	Publication Date
GB9102727D0 true GB9102727D0 (en)	1991-03-27

Family

ID=10689748

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GB919102727A Pending GB9102727D0 (en)	1991-02-08	1991-02-08	Pharmaceutical agent
GB9202377A Withdrawn GB2252557A (en)	1991-02-08	1992-02-05	Quinoline derivative

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
GB9202377A Withdrawn GB2252557A (en)	1991-02-08	1992-02-05	Quinoline derivative

Country Status (12)

Country	Link
CN (1)	CN1064809A (en)
AP (1)	AP9200355A0 (en)
AU (1)	AU1189392A (en)
CA (1)	CA2060825A1 (en)
GB (2)	GB9102727D0 (en)
HU (1)	HUT60489A (en)
IE (1)	IE920243A1 (en)
IL (1)	IL100793A0 (en)
MX (1)	MX9200532A (en)
PT (1)	PT100097A (en)
WO (1)	WO1992013853A1 (en)
ZA (1)	ZA92729B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW297025B (en) *	1992-02-14	1997-02-01	Squibb & Sons Inc
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en)	2007-06-04	2008-12-11	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009149279A2 (en)	2008-06-04	2009-12-10	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en)	2008-07-16	2019-09-24	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
WO2014151200A2 (en)	2013-03-15	2014-09-25	Synergy Pharmaceuticals Inc.	Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en)	2013-03-15	2016-01-20	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
AU2014274812B2 (en)	2013-06-05	2018-09-27	Bausch Health Ireland Limited	Ultra-pure agonists of guanylate cyclase C, method of making and using same
DK3046584T3 (en)	2013-09-16	2017-10-02	Astrazeneca Ab	THERAPEUTIC POLYMER NANOPARTICLES AND PROCEDURES FOR PREPARING AND USING THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4920132A (en) *	1987-11-03	1990-04-24	Rorer Pharmaceutical Corp.	Quinoline derivatives and use thereof as antagonists of leukotriene D4
ATE117294T1 (en) *	1989-08-11	1995-02-15	Ici Plc	QUINOLINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS.

1991
- 1991-02-08 GB GB919102727A patent/GB9102727D0/en active Pending
1992
- 1992-01-27 IE IE024392A patent/IE920243A1/en unknown
- 1992-01-28 IL IL100793A patent/IL100793A0/en unknown
- 1992-01-31 ZA ZA92729A patent/ZA92729B/en unknown
- 1992-02-03 AP APAP/P/1992/000355A patent/AP9200355A0/en unknown
- 1992-02-05 GB GB9202377A patent/GB2252557A/en not_active Withdrawn
- 1992-02-05 AU AU11893/92A patent/AU1189392A/en not_active Abandoned
- 1992-02-05 HU HU9200354A patent/HUT60489A/en unknown
- 1992-02-05 WO PCT/GB1992/000214 patent/WO1992013853A1/en not_active Ceased
- 1992-02-06 PT PT100097A patent/PT100097A/en not_active Application Discontinuation
- 1992-02-07 CA CA002060825A patent/CA2060825A1/en not_active Abandoned
- 1992-02-07 MX MX9200532A patent/MX9200532A/en unknown
- 1992-02-08 CN CN92101425A patent/CN1064809A/en active Pending

Also Published As

Publication number	Publication date
MX9200532A (en)	1992-08-01
CN1064809A (en)	1992-09-30
IE920243A1 (en)	1992-08-12
ZA92729B (en)	1992-11-25
PT100097A (en)	1993-04-30
GB2252557A (en)	1992-08-12
IL100793A0 (en)	1992-09-06
WO1992013853A1 (en)	1992-08-20
AU1189392A (en)	1992-09-07
AP9200355A0 (en)	1993-08-03
HUT60489A (en)	1992-09-28
HU9200354D0 (en)	1992-04-28
CA2060825A1 (en)	1992-08-09
GB9202377D0 (en)	1992-03-18

Publication	Publication Date	Title
PL304317A1 (en)	1995-01-23	Pharmaceutical agent
IL100091A0 (en)	1992-08-18	Pharmaceutical agents
IL102777A0 (en)	1993-01-31	Pharmaceutical combination formulation
PL304508A1 (en)	1995-02-06	Pharmaceutical agent
GB9108080D0 (en)	1991-06-05	Pharmaceutical composition
AP9200356A0 (en)	1992-04-30	Pharmaceutical composition
GB9114950D0 (en)	1991-08-28	Pharmaceutical formulation
HU9300804D0 (en)	1993-06-28	Pharmaceutical preparatives
GB9102727D0 (en)	1991-03-27	Pharmaceutical agent
GB9216061D0 (en)	1992-09-09	Pharmaceutical combination formulation
GB9111477D0 (en)	1991-07-17	Pharmaceutical composition
GB9000241D0 (en)	1990-03-07	Pharmaceutical use
GB2252497B (en)	1995-01-18	Pharmaceutical composition
PL297548A1 (en)	1994-08-08	Pharmaceutical agent
GB9104123D0 (en)	1991-04-17	Pharmaceutical agent
GB9104124D0 (en)	1991-04-17	Pharmaceutical agent
GB9115107D0 (en)	1991-08-28	Pharmaceutical agents
GB9113622D0 (en)	1991-08-14	Medicinal agents
ZA924842B (en)	1993-09-16	Asialoglycoprotein-conjugated medicinal agent
GB9113918D0 (en)	1991-08-14	New pharmaceutical use
GB9123202D0 (en)	1991-12-18	New pharmaceutical use
GB9104269D0 (en)	1991-04-17	New pharmaceutical use
GB9104306D0 (en)	1991-04-17	New pharmaceutical use
GB9123204D0 (en)	1991-12-18	New pharmaceutical use
GB9104307D0 (en)	1991-04-17	New pharmaceutical use